Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - GENEREX BIOTECHNOLOGY CORP | ex31_2.htm |
| EX-31.1 - EXHIBIT 31.1 - GENEREX BIOTECHNOLOGY CORP | ex31_1.htm |
| 10-Q - FORM 10-Q - GENEREX BIOTECHNOLOGY CORP | gnbt013116form10q.htm |
Exhibit 32
CERTIFICATIONS
Pursuant to Section 906 of the Public Company Accounting Reform and Investor Protection Act of 2002 (18 U.S.C. ss. 1350, as adopted), Mark A. Fletcher, Chief Executive Officer and President of Generex Biotechnology Corporation (the "Company"), and Stephen Fellows, Chief Financial Officer of the Company, each hereby certifies that, to the best of their knowledge:
1. The Company's Quarterly Report on Form 10-Q for the period ended January 31, 2016 to which this Certification is attached as Exhibit 32 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the end of the period covered by the Report.
| DATE: July 20, 2016 | By: | /s/ Mark A. Fletcher |
| Mark A. Fletcher | ||
| President & Chief Executive Officer | ||
| (Principal Executive Officer) | ||
| DATE: July 20, 2016 | By: | /s/ David Brusegard |
| David Brusegard | ||
| Chief Operating Officer | ||
| (Principal Operating Officer) | ||